The  Sixteenth Meeting of the Parties  decided in  Dec. XVI/16:     Recalling  decision IX/17 on essential-use exemptions for laboratory and analytical uses of ozone-depleting substances,    Noting  the report of the Implementation Committee requesting guidance from the Parties on the use of bromochloromethane for laboratory and analytical uses,    Considering  that decision XV/8 requests the Technology and Economic Assessment Panel to report annually on the development and availability of laboratory and analytical procedures that can be performed without using controlled substances in Annexes A, B and C, groups II and III, of the Protocol,     To include in the global laboratory and analytical use exemption under the conditions set out in annex II of the report of the Sixth Meeting of the Parties substances in Annex C, groups II and III, of the Protocol,   To apply the conditions set out in paragraphs 3, 4 and 5 of decision X/19 to paragraph 1 of the present decision.